Biotronik considering selling its stents and balloon catheter business

Quote

anonymous

Guest
  • Biotronik on the Block: Reports out of Germany suggest that Biotronik is considering selling its €400M Stents and Balloon Catheters business for up to €1B, as the company looks to focus on its core operations and pay down its €600M in debt. Biotronik has reportedly enlisted Goldman Sachs to guide the transaction, and insiders expect that the unit will be acquired by financial investors rather than by another major medtech player.
 






anonymous said:
  • Biotronik on the Block: Reports out of Germany suggest that Biotronik is considering selling its €400M Stents and Balloon Catheters business for up to €1B, as the company looks to focus on its core operations and pay down its €600M in debt. Biotronik has reportedly enlisted Goldman Sachs to guide the transaction, and insiders expect that the unit will be acquired by financial investors rather than by another major medtech player.
Click to expand...

Max will make a boatload!
 






anonymous said:
Max will make a boatload!
Click to expand...
Ain’t no way the BIO VI business is worth $1B. Yes, there are some unique and top or near top of class products in the portfolio, but if BIO has learned anything over its 65+ year history, it’s that best technology/best quality isn’t a guaranteed recipe for financial success. Big brother Medtronic has grown to be the world’s largest med tech on some pretty mediocre products and very checkered history of quality. I’d be shocked if the deal went through for more than $600m and even that’s a stretch.
 


















Top Bottom
Back
Quote